EDWARDS LIFESCIENCES CORP (EWL.DE) Forecast, Price Target & Analyst Ratings
FRA:EWL • US28176E1082
69.99 EUR
-2.51 (-3.46%)
Last: Mar 6, 2026, 07:00 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for EDWARDS LIFESCIENCES CORP (EWL.DE).
Forecast Snapshot
Consensus Price Target
€81.61
+ 16.60% Upside
Next Earnings Forecast
Release DateApr 21, 2026
PeriodQ1 / 2026
EPS Estimate$0.75
Revenue Estimate1.645B
ChartMill Buy Consensus
79.53%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
€81.61
Upside
+ 16.60%
From current price of €69.99 to mean target of €81.61, Based on 43 analyst forecasts
Low
€60.90
Median
€84.57
High
€96.73
Price Target Revisions
1 Month
-1.50%
3 Months
-0.09%
Price Target Summary
43 analysts have analysed EWL.DE and the average price target is 81.61 EUR. This implies a price increase of 16.6% is expected in the next year compared to the current price of 69.99.
The average price target has been revised downward by 0.09% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
79.53%
EWL.DE was analyzed by 43 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about EWL.DE.
In the previous month the buy percentage consensus was at a similar level.
EWL.DE was analyzed by 43 analysts, which is quite many. So the average rating should be quite meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2021-08-03 | Goldman Sachs | Maintains | Neutral |
| 2021-08-02 | Raymond James | Maintains | Outperform |
| 2021-07-30 | Deutsche Bank | Maintains | Hold |
| 2021-07-30 | SVB Leerink | Maintains | Outperform |
| 2021-07-30 | Wells Fargo | Maintains | Equal-Weight |
| 2021-07-30 | Canaccord Genuity | Maintains | Buy |
| 2021-07-30 | Credit Suisse | Maintains | Outperform |
| 2021-07-30 | Morgan Stanley | Maintains | Overweight |
| 2021-07-30 | Piper Sandler | Maintains | Overweight |
| 2021-07-30 | Jefferies | Maintains | Buy |
| 2021-07-27 | Piper Sandler | Maintains | Overweight |
| 2021-07-20 | SVB Leerink | Maintains | Outperform |
| 2021-05-25 | Barclays | Initiate | Overweight |
| 2021-04-21 | Raymond James | Maintains | Outperform |
| 2021-04-21 | Canaccord Genuity | Maintains | Buy |
| 2021-04-21 | Morgan Stanley | Maintains | Overweight |
| 2021-04-21 | Piper Sandler | Maintains | Overweight |
| 2021-04-15 | Atlantic Equities | Initiate | Neutral |
| 2021-04-05 | Evercore ISI Group | Upgrade | In-Line -> Outperform |
Next Earnings Forecast Details
Next Earnings Details
Release DateApr 21, 2026
PeriodQ1 / 2026
EPS Estimate$0.75
Revenue Estimate1.645B
Revenue Q2Q16.44%
EPS Q2Q16.90%
Number of Analysts30
Next Earnings Revisions
Revenue (1 Month)
1.79%
Revenue (3 Months)
1.48%
EPS (1 Month)
5.87%
EPS (3 Months)
6.38%
Next Earnings Summary
EWL.DE is expected to report earnings on 4/21/2026. The consensus EPS estimate for the next earnings is 0.75 EUR and the consensus revenue estimate is 1.65B EUR.
The next earnings revenue estimate has been revised upward by 1.48% in the past 3 months.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 5.01B 12.23% | 5.44B 8.57% | 6.068B 11.55% | 6.88B 13.39% | 7.553B 9.78% | 8.304B 9.94% | 9.016B 8.57% | 9.887B 9.66% | |
| EBITDA YoY % growth | 1.657B -3.34% | 1.635B -1.33% | 1.805B 10.40% | 2.15B 19.09% | 2.405B 11.86% | 2.673B 11.14% | 2.92B 9.24% | 3.354B 14.86% | |
| EBIT YoY % growth | 1.512B -3.97% | 1.48B -2.14% | 1.649B 11.39% | 1.967B 19.31% | 2.206B 12.15% | 2.496B 13.15% | 2.736B 9.62% | 3.041B 11.15% | |
| Operating Margin | 30.19% | 27.21% | 27.17% | 28.59% | 29.21% | 30.06% | 30.35% | 30.76% | |
| EPS YoY % growth | 2.51 1.21% | 2.62 4.38% | 2.56 -2.29% | 3.01 17.70% | 3.37 11.97% | 3.80 12.61% | 4.27 12.50% | 4.69 9.80% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.75 16.90% | 0.77 15.09% | 0.75 12.67% | 0.75 28.85% | 0.76 2.22% | 0.83 7.19% | 0.83 10.52% | 0.87 16.46% |
| Revenue Q2Q % growth | 1.645B 16.44% | 1.734B 13.17% | 1.737B 11.84% | 1.745B 11.17% | 1.747B 6.20% | 1.88B 8.42% | 1.875B 7.94% | 1.937B 11.00% |
| EBITDA Q2Q % growth | 529.52M 18.59% | 547.36M 8.26% | 537.71M -2.50% | 532.86M 1.13% | 561.05M 5.95% | 600.97M 9.79% | 607.22M 12.93% | 625.27M 17.34% |
| EBIT Q2Q % growth | 486.72M 18.74% | 503.84M 16.93% | 495.88M 13.32% | 490.25M 32.39% | 504.63M 3.68% | 544.99M 8.17% | 549.32M 10.78% | 584.45M 19.21% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
14.07%
EPS Next 5 Year
12.89%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
10.13%
Revenue Next 5 Year
9.72%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
16.10%
EBIT Next 5 Year
14.45%
EDWARDS LIFESCIENCES CORP / EWL.DE Forecast FAQ
What do analysts expect the price target to be for EDWARDS LIFESCIENCES CORP (EWL.DE)?
43 analysts have analysed EWL.DE and the average price target is 81.61 EUR. This implies a price increase of 16.6% is expected in the next year compared to the current price of 69.99.
When does EDWARDS LIFESCIENCES CORP (EWL.DE) report earnings?
EDWARDS LIFESCIENCES CORP (EWL.DE) will report earnings on 2026-04-21, after the market close.
What are the consensus estimates for EWL stock next earnings?
The consensus EPS estimate for the next earnings of EDWARDS LIFESCIENCES CORP (EWL.DE) is 0.75 EUR and the consensus revenue estimate is 1.65B EUR.
What is the consensus rating for EDWARDS LIFESCIENCES CORP (EWL.DE) stock?
The consensus rating for EDWARDS LIFESCIENCES CORP (EWL.DE) is 79.5349 / 100 . This indicates that analysts generally have a positive outlook on the stock.